论文部分内容阅读
目的:评价慢性心力衰竭(CHF)住院患者的治疗用药。方法:采用回顾性分析方法,将384例CHF住院患者分为左心室射血分数(LVEF)正常组和LVEF减少组,调查其使用利尿药、螺内酯、血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体拮抗药、β-受体阻滞药、洋地黄制剂、非洋地黄类正性肌力药和钙离子通道阻滞药的情况。结果:LVEF正常组在β-受体阻滞药、螺内酯、洋地黄制剂治疗方面与2005年美国心脏病学会/美国心脏协会的《慢性心力衰竭治疗指南》存在差距。结论:LVEF正常的CHF合理用药水平有待提高。
Objective: To evaluate the treatment of hospitalized patients with chronic heart failure (CHF). Methods: A retrospective analysis of 384 CHF inpatients was divided into normal left ventricular ejection fraction (LVEF) group and LVEF reduction group, to investigate the use of diuretics, spironolactone, angiotensin converting enzyme inhibitor / angiotensin Ⅱ receptor antagonists, β-blockers, digitalis preparations, non-digitalis inotropic drugs and calcium channel blockers. Results: There was a gap between the LVEF group and the 2005 American College of Cardiology / American Heart Association guidelines for the treatment of chronic heart failure in the treatment of β-blockers, spironolactone and digitalis preparations. Conclusion: The reasonable dosage of CHF with normal LVEF needs to be improved.